|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,440,855,835 |
|
|
Indirect Value
|
$7,314,725,181 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,755,581,016 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMAG |
AMAG Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-08-13 |
4 |
B |
$8.78 |
$189,585 |
I/I |
21,600 |
1,438,333 |
1.5 |
- |
|
DVAX |
Dynavax Technologies Corp |
Indirect Beneficial Owner |
|
2009-04-27 |
4 |
S |
$1.30 |
$28,600 |
I/I |
(22,000) |
8,110,657 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-05-28 |
4 |
B |
$4.72 |
$104,312 |
I/I |
22,100 |
5,054,800 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-28 |
4 |
B |
$5.00 |
$115,000 |
I/I |
23,000 |
3,913,100 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-04 |
4 |
B |
$4.97 |
$115,418 |
I/I |
23,200 |
4,081,700 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-13 |
4 |
B |
$4.92 |
$117,531 |
I/I |
23,900 |
4,678,500 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-07-25 |
4 |
B |
$8.99 |
$215,760 |
I/I |
24,000 |
1,416,733 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-09 |
4 |
S |
$6.30 |
$151,200 |
I/I |
(24,000) |
1,672,351 |
|
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-01-14 |
4 |
B |
$4.50 |
$111,600 |
I/I |
24,800 |
5,955,577 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2009-01-21 |
4 |
B |
$3.06 |
$77,097 |
I/I |
25,200 |
5,930,647 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-13 |
4 |
B |
$0.65 |
$16,550 |
I/I |
25,500 |
5,084,799 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-05-16 |
4 |
B |
$4.65 |
$122,358 |
I/I |
26,300 |
5,027,700 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-02 |
4 |
B |
$4.18 |
$111,098 |
I/I |
26,600 |
5,081,400 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$0.55 |
$14,740 |
I/I |
26,800 |
8,444,799 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-03 |
4 |
B |
$1.95 |
$54,080 |
I/I |
27,739 |
13,412,692 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-02-20 |
4 |
B |
$5.05 |
$141,905 |
I/I |
28,100 |
7,923,577 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-05 |
4 |
B |
$1.98 |
$56,065 |
I/I |
28,283 |
13,537,275 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-23 |
4 |
S |
$2.75 |
$79,750 |
D/D |
(29,000) |
5,845,547 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-26 |
4 |
S |
$2.70 |
$84,249 |
D/D |
(31,200) |
5,421,547 |
0 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-30 |
4 |
B |
$2.94 |
$92,667 |
I/I |
31,500 |
6,213,551 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-02-19 |
4 |
B |
$5.10 |
$164,707 |
I/I |
32,300 |
7,895,477 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-19 |
4 |
B |
$1.39 |
$45,906 |
I/I |
33,000 |
10,777,709 |
1.5 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-03-12 |
4 |
B |
$3.82 |
$147,452 |
I/I |
38,600 |
4,700,715 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2009-01-23 |
4 |
B |
$2.00 |
$79,456 |
I/I |
39,728 |
16,002,207 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
officerTitle |
|
2005-01-13 |
4 |
S |
$15.40 |
$670,978 |
I/I |
(43,570) |
985,163 |
|
- |
|
195 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|